Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

peripheral neuropathy - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

peripheral neuropathy

MONDO:0005244

Also known as:neuropathyperipheral nerve disorder

Find Clinical TrialsTrials

Overview

A disorder affecting the peripheral nervous system. It manifests with pain, tingling, numbness, and muscle weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs.

Clinical Trials376 registered · 142 recruiting

Patient Orgs1 organizations · Foundation for Peripheral Neuropathy

Diagnosis

Biomarker and diagnostic research for peripheral neuropathy has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

376 clinical trials registered, 142 recruiting. Interventions under study include other interventions, medical devices, drug therapy, and procedural interventions. Pipeline includes 7 PHASE4, 19 PHASE3, 43 PHASE2. Research is sponsored by a mix of industry and academic institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT06430814](https://clinicaltrials.gov/study/NCT06430814)

Data assembled from 3 of 12 sources · Last updated Oct 3, 2026, 3:00 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Patient Support

Patient Advocacy Groups

View all PAGs →

Foundation for Peripheral NeuropathyPrimary Focus

USWebsite ↗

Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.

Are you a patient organization not listed here? Claim this page to be listed and embed this content on your site — free.

Medical References

External Resources

GARD

Genetic and Rare Diseases Info Center

GARD:12192

Questions for Your Care Team

→Are any of the 376 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→How can I connect with Foundation for Peripheral Neuropathy and other patient organizations for support?

← Back to All Diseases

Research Type	Count	% of Total
Research summaries	173	41%
Disease patterns and progression	81	19%
Laboratory research	45	11%
Clinical study results	36	9%
Testing and diagnosis research	33	8%
Patient case studies	30	7%
New treatment approaches	12	3%
Other research	10	2%

Kisho

peripheral neuropathy

Overview

Diagnosis

Research Landscape

Patient Support

Patient Advocacy Groups

Medical References

External Resources

GARD

Questions for Your Care Team

Questions for Your Care Team

Recent Publications

Latest News & Developments

Peripheral neuropathy in a mouse model lacking GBA1 in Schwann cells.

Uncovering Neuropathic Pain in CANVAS: Lessons from a Case-Based Literature Review.

World Trade Center Health Program; Petitions 032, 033, and 068-Peripheral Neuropathy; Finding of Insufficient Evidence

Severe peripheral neuropathy secondary to acute intermittent porphyria caused by a rare HMBS gene mutation: a case report.

peripheral neuropathy

Overview

Diagnosis

Research Landscape

Patient Support

Patient Advocacy Groups

Medical References

External Resources

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications

Latest News & Developments

Peripheral neuropathy in a mouse model lacking GBA1 in Schwann cells.

Uncovering Neuropathic Pain in CANVAS: Lessons from a Case-Based Literature Review.

World Trade Center Health Program; Petitions 032, 033, and 068-Peripheral Neuropathy; Finding of Insufficient Evidence

Severe peripheral neuropathy secondary to acute intermittent porphyria caused by a rare HMBS gene mutation: a case report.